Effects of ketorolac and pethidine on pain control and duration of analgesia
Phase 2
- Conditions
- Pain.Pain, unspecified
- Registration Number
- IRCT2016101317756N8
- Lead Sponsor
- Vice-chancellery for Reasearch at Birjand University of Medicla Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 102
Inclusion Criteria
Candidates for elective caesarean section willing to participate; lack of dependency on opioids, atopy and bronchial asthma, diabetes, renal and hepatic disease, alcohol or drugs abuse, gestational hypertension, preeclampsia and peptic ulcer disease, multiple pregnancy, obesity, infant macrosomia; exclusion criteria: unwillingness to continue participation.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain intensity. Timepoint: 4 hours after treatment. Method of measurement: Faces Pain Scale and Visual Analog Scale (VAS).;Anelgesic duration. Timepoint: From end of intervention until first pain onset. Method of measurement: patient self-report.
- Secondary Outcome Measures
Name Time Method